Hantz Financial Services’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6K Hold
4,232
﹤0.01% 2182
2026
Q1
$6K Sell
4,232
-68
-2% -$103 ﹤0.01% 2149
2025
Q4
$6K Hold
4,300
﹤0.01% 2112
2025
Q3
$5K Hold
4,300
﹤0.01% 2017
2025
Q2
$6K Hold
4,300
﹤0.01% 1696
2025
Q1
$6K Hold
4,300
﹤0.01% 1114
2024
Q4
$9K Hold
4,300
﹤0.01% 830
2024
Q3
$9K Buy
4,300
+2,500
+139% +$3.7K ﹤0.01% 809
2024
Q2
$3K Hold
1,800
﹤0.01% 923
2024
Q1
$3K Hold
1,800
﹤0.01% 1017
2023
Q4
$3K Buy
+1,800
New +$3.25K ﹤0.01% 990

Other funds holding MNOV

Hantz Financial Services's MNOV Position: Q2 2026 in Review

Hantz Financial Services held its MediciNova (MNOV) position steady in Q2 2026 at 4,232 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Hantz Financial Services first reported a position in MNOV in Q4 2023 and has held it in 11 quarters since. The position peaked at $9K in Q4 2024. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • Hantz Financial Services held 4,232 shares of MediciNova worth $6K as of Q2 2026.
  • Hantz Financial Services left its MediciNova share count unchanged in Q2 2026.
  • MediciNova made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2182 holding.
  • Hantz Financial Services first reported a position in MediciNova in Q4 2023 and has held it in 11 quarters since.
  • Hantz Financial Services's MediciNova position peaked at $9K in Q4 2024.
  • 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.